MedPlus is in a funk. Can Reddy’s private-label push revive it?
India’s only listed pharma retailer wants to rev up growth by boosting its own-brand business. But will it be enough to overcome its mounting debt, slowing revenue growth and a stalled fundraise?
3 July, 2024•11 min
0
3 July, 2024•11 min
0
More in Business
Business
RBI wants IndusInd Bank promoters, the Hindujas, cut to size
After successive controversies and growing unease over promoter influence, the central bank is reshaping the lender—starting with management, moving to its board and tightening the screws on ownership.
You may also like
Internet
SuperK has a playbook for solving India’s small-town retail problem
Investors are betting on the value retail chain’s franchise model to disrupt the retail market in small-town India. By the looks of it, the six-year-old startup seems to have gotten a lot of things right.
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Business
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.